Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study. (14th July 2021)

Record Type:: Journal Article
Title:: Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study. (14th July 2021)
Main Title:: Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study
Authors:: Van Voorhees, A.S.
Stein Gold, L.
Lebwohl, M.
Strober, B.
Sofen, H.
Papp, K.
Bagel, J.
Zhang, Z.
Paris, M.
Wang, Y.
Abstract:
Is Part Of:: British journal of dermatology. Volume 185:Number 4(2021)
Journal:: British journal of dermatology
Issue:: Volume 185:Number 4(2021)
Issue Display:: Volume 185, Issue 4 (2021)
Year:: 2021
Volume:: 185
Issue:: 4
Issue Sort Value:: 2021-0185-0004-0000
Page Start:: 840
Page End:: 842
Publication Date:: 2021-07-14
Subjects:: Dermatology -- Periodicals
Skin -- Diseases -- Periodicals
616.5
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2133 ↗
https://academic.oup.com/bjd ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/bjd.20083 ↗
Languages:: English
ISSNs:: 0007-0963
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2307.400000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 19778.xml